Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 2015 Guidelines for Cardiopulmonary Resuscitation and survival after adult and paediatric out-of-hospital cardiac arrest.1 passage
• A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999-2018.1 passage
• A meta-analysis of randomized controlled trials to compare long-term clinical outcomes of bioabsorbable polymer and durable polymer drug-eluting stents.1 passage
• A novel geriatric assessment frailty score predicts 2-year mortality after transcatheter aortic valve implantation.1 passage
• A real-world cohort study on the quality of potassium and creatinine monitoring during initiation of mineralocorticoid receptor antagonists in patients with heart failure.1 passage
• A risk prediction model in asymptomatic patients with severe aortic stenosis: CURRENT-AS risk score.1 passage
• A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.1 passage
• A tale of two countries: how decentralized organization and long-term investment build resilient healthcare systems.1 passage
• A user-centred home monitoring and self-management system for patients with heart failure: a multicentre cohort study.1 passage
• Acute coronary syndrome registry enrolment status: Differences in patient characteristics and outcomes and implications for registry data use (ANZACS-QI 36).1 passage
• Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation.1 passage
• Adherence to quality indicators for ST-elevation myocardial infarction and its relation to mortality: a hospital network analysis from the Belgian STEMI database.1 passage
• Adherence to risk-assessment protocols to guide computed tomography pulmonary angiography in patients with suspected pulmonary embolism.1 passage
• Admission macrophage migration inhibitory factor predicts long-term prognosis in patients with ST-elevation myocardial infarction.1 passage
• Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology.1 passage
• Admission rates and care pathways in patients with atrial fibrillation during the COVID-19 pandemic-insights from the German-wide Helios hospital network.1 passage
• An economic analysis of medical and surgical management of aortopathy associated with bicuspid aortic valve.1 passage
• Angina Frequency After Acute Myocardial Infarction In Patients Without Obstructive Coronary Artery Disease.1 passage
• Angiography- vs. physiology-guided complete revascularization in patients with ST-elevation myocardial infarction and multivessel disease: who is the better gatekeeper in this setting? A meta-analysis of randomized controlled trials.1 passage
• Anti-anginal medication titration among patients with residual angina 6-months after chronic total occlusion percutaneous coronary intervention: insights from OPEN CTO registry.1 passage
• Anticoagulation to prevent ischaemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment, or underdosing of oral anticoagulants.1 passage
• Are non-ST-segment elevation myocardial infarctions missing in China?1 passage
• Assessing the quality of reporting of harms in randomized controlled trials published in high impact cardiovascular journals.1 passage
• Association between atrial fibrillation and patient-important outcomes in heart failure patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis.1 passage
• Association between heart failure and perioperative outcomes in patients undergoing non-cardiac surgery.1 passage
• Association between multimodality measures of aortic stenosis severity and quality-of-life improvement outcomes after transcatheter aortic valve replacement.1 passage
• Association between process performance measures and 1-year mortality among patients with incident heart failure: a Danish nationwide study.1 passage
• Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction.1 passage
• Association of admitting physician specialty and care quality and outcomes in non-ST-segment elevation myocardial infarction (NSTEMI): insights from a national registry.1 passage
• Association of autoimmune diseases with cardiomyopathy: a nationwide follow-up study from Sweden.1 passage
• Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer.1 passage
• Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF Registry.1 passage
• Asymptomatic cerebral infarction is a predictor of long-term survival and vascular or limb events in peripheral arterial disease.1 passage
• Atrial Fibrillation in the United Kingdom: Predicting Costs of an Emerging Epidemic Recognising and Forecasting the Cost Drivers of Atrial Fibrillation-related costs.1 passage
• Atypical chest pain in diabetic patients with suspected stable angina: impact on diagnosis and coronary outcomes.1 passage
• Barriers and facilitators to public access defibrillation in out-of-hospital cardiac arrest: a systematic review.1 passage
• Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.1 passage
• Big biomedical data and cardiovascular disease research: opportunities and challenges.1 passage
• Biodegradable polymer drug-eluting stent vs. contemporary durable polymer drug-eluting stents in patients with diabetes: a meta-analysis of randomized controlled trials.1 passage
• British Cardiovascular Intervention Society registry framework: a quality improvement initiative on behalf of the National Institute of Cardiovascular Outcomes Research (NICOR).1 passage
• C-reactive protein level on admission and time to and cause of death in patients hospitalized for acute heart failure.1 passage
• COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry.1 passage
• Can activity monitors predict outcomes in patients with heart failure? A systematic review.1 passage
• Cardiac Rehabilitation for Patients with Heart failure: Association With Readmission and Mortality Risk.1 passage
• Cardiac rehabilitation fitness changes and subsequent survival.1 passage
• Cardiac rehabilitation in patients with acute coronary syndrome with primary percutaneous coronary intervention is associated with improved 10-year survival.1 passage
• Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.1 passage
• Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data.1 passage
• Cardiovascular hazards of insufficient treatment of depression among patients with known cardiovascular disease: a propensity score adjusted analysis.1 passage
• Cardiovascular long-term outcome and prophylactic treatment patterns in peripheral arterial disease in a population-based cohort.1 passage
• Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years.1 passage
• Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews.1 passage
• Case-ascertainment of acute myocardial infarction hospitalisations in cancer patients: a cohort study using English linked electronic health data.1 passage
• Cause-specific death and risk factors of one-year mortality after implantable cardioverter-defibrillator implantation: a nationwide study.1 passage
• Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry.1 passage
• Causes, Pattern, Predictors and Prognostic Implications of New Hospitalizations after TAVI: A Long-Term Nationwide Observational Study.1 passage
• Changes in symptoms of anxiety and depression following diagnostic angiography: a prospective cohort study.1 passage
• Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.1 passage
• Characteristics of neighbourhoods with high incidence of out-of-hospital cardiac arrest and low bystander cardiopulmonary resuscitation rates in England.1 passage
• Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes.1 passage
• Chronic obstructive pulmonary disease and myocardial infarction: when will we get our act together?1 passage
• Clinical outcomes in patients with primary stable microvascular angina: is the jury still out?1 passage
• Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization.1 passage
• Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study.1 passage
• Clinical risk prediction models for the prognosis and management of acute coronary syndromes.1 passage
• Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry.1 passage
• Combinations of cardiac and non-cardiac predictors for prognoses in patients with acute heart failure.1 passage
• Comparative analysis of recurrent events after presentation with an index myocardial infarction or ischaemic stroke.1 passage
• Comparative cost-effectiveness of non-invasive imaging tests in patients presenting with chronic stable chest pain with suspected coronary artery disease: a systematic review.1 passage
• Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials.1 passage
• Comparative overview of ST-elevation myocardial infarction epidemiology, demographics, management, and outcomes in five Asia-Pacific countries: a meta-analysis.1 passage
• Comparison of EQ-5D and 15D instruments for assessing the health-related quality of life in cardiac surgery patients.1 passage
• Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry.1 passage
• Comparison of long-term mortality between living alone patients vs. living together patients with acute coronary syndrome treated with percutaneous coronary intervention.1 passage
• Comparison of long-term mortality between patients living alone vs. patients living with others with acute coronary syndrome treated with percutaneous coronary intervention: reply.1 passage
• Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway and Sweden according to national ongoing registries.1 passage
• Coordinated regional care of myocardial infarction in a rural area in Brazil: Minas Telecardio Project 2.1 passage
• Correspondence to European Heart Journal-Quality of Care and Clinical Outcomes in response to paper by Thomas, M. et al. 2021: Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with heart failures.1 passage
• Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve.1 passage
• Cost-effectiveness of PCSK9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden.1 passage
• Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention.1 passage
• Cost-effectiveness of bilateral versus single internal thoracic artery grafts at ten years.1 passage
• Cost-effectiveness of colchicine treatment on post-operative atrial fibrillation events in patients of major cardiac surgery.1 passage
• Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease.1 passage
• Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).1 passage
• Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients.1 passage
• Cumulative hospitalization deficit for cardiovascular disorders in Germany during the COVID-19 pandemic: insights from the German-wide Helios hospital network.1 passage
• Development of an international standard set of clinical and patient-reported outcomes for children and adults with congenital heart disease: a report from the International Consortium for Health Outcomes Measurement Congenital Heart Disease Working Group.1 passage
• Diabetes Mellitus And Outcomes Of Lower Extremity Revascularization For Peripheral Artery Disease.1 passage
• Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction -novel insights from four national European continuous real-world registries.1 passage
• Do patients suffering an out-of-hospital cardiac arrest present to the ambulance service with symptoms in the preceding 48 h?1 passage
• Does heart failure-specific health status identify patients with bothersome symptoms, depression, anxiety, and/or poorer spiritual well-being?1 passage
• Does objectively measured light-intensity physical activity reduce the risk of cardiovascular mortality? A meta-analysis.1 passage
• Does routinely collected patient-reported outcome data represent the actual case-mix of elective coronary revascularization patients?1 passage
• Does the subtype of acute coronary syndrome treated by percutaneous coronary intervention predict long-term clinical outcomes?1 passage
• Door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty.1 passage
• Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study.1 passage
• Economic burden of patients living with heart disease in the last years of life in Australia; a retrospective analysis using linked data.1 passage
• Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands.1 passage
• Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease.1 passage
• Effect of coronary artery bypass grafting on quality of life: a meta-analysis of randomized trials.1 passage
• Effect of impaired cardiac conduction after alcohol septal ablation on clinical outcomes: insights from the Euro-ASA registry.1 passage
• Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study.1 passage
• Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF.1 passage
• Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak: insights from the German-wide Helios hospital network.1 passage
• Estimating the cost-effectiveness of screening a general population for cardiovascular risk with high-sensitivity troponin-I.1 passage
• Ethnic disparities in care and outcomes of non-ST-segment elevation myocardial infarction: a nationwide cohort study.1 passage
• European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes.1 passage
• Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy.1 passage
• Evaluating the extent of patient-centred care in a selection of ESC guidelines.1 passage
• Evolving quality standards for large-scale registries: the GARFIELD-AF experience.1 passage
• Exploring optimal heart team protocol to improve decision-making stability for complex coronary artery disease: a sequential explanatory mixed method study.1 passage
• Factors related to outcome in heart failure with a preserved (or normal) left ventricular ejection fraction.1 passage
• Fractional flow reserve for non-culprit disease in ST-segment elevation myocardial infarction: first do no harm?1 passage
• Frailty to predict unplanned hospitalization, stroke, bleeding, and death in atrial fibrillation.1 passage
• Functional performance and quality of life in high-risk comorbid patients undergoing transcatheter aortic valve implantation for symptomatic aortic valve stenosis.1 passage
• GARFIELD-AF risk score for mortality, stroke and bleeding within 2 years in patients with atrial fibrillation.1 passage
• Gaps in patient-reported outcome measures in randomized clinical trials of cardiac catheter ablation: a systematic review.1 passage
• Gender differences in complications following catheter ablation of atrial fibrillation.1 passage
• Generalisability of Randomised Controlled Trials in Heart Failure with Reduced Ejection Fraction.1 passage
• Global Representation of Heart Failure Clinical Trial Leaders, Collaborators, and Enrolled Participants: A Bibliometric Review 2000-2020.1 passage
• Global, regional, and national burden of ischemic heart disease and its attributable risk factors, 1990-2017: results from the global Burden of Disease Study 2017.1 passage
• Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: results from the Global Burden of Disease Study 2017.1 passage
• Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey.1 passage
• Has invasive management for acute coronary syndromes become more 'risk-appropriate': pooled results of five Australian registries.1 passage
• Health Impact of Tafamidis in Transthyretin Amyloid Cardiomyopathy patients: An Analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the Open-Label Long-term Extension Studies.1 passage
• Health Outcomes Management Evaluation-A National Analysis of Dutch Heart Care.1 passage
• Healthcare disparities for women hospitalized with myocardial infarction and angina.1 passage
• High Statin Adherence over 5 Years of Follow-up is Associated with Improved Cardiovascular Outcomes in Patients with Atherosclerotic Cardiovascular Disease: Results from the IMPRES Study.1 passage
• High-sensitivity cardiac troponin I and risk of heart failure in patients with suspected acute coronary syndrome: a cohort study.1 passage
• Hospital readmission following takotsubo syndrome.1 passage
• How should CT coronary angiography be integrated into the management of patients with chest pain and how does this affect outcomes?1 passage
• Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality.1 passage
• Impact of achieved systolic blood pressure on renal function in hypertensive patients.1 passage
• Impact of additive mitral valve surgery to coronary artery bypass grafting on mortality in patients with coronary artery disease and ischaemic mitral regurgitation: a systematic review and meta-analysis of randomized trials and observational studies.1 passage
• Impact of co-morbid burden on mortality in patients with coronary heart disease, heart failure, and cerebrovascular accident: a systematic review and meta-analysis.1 passage
• Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry.1 passage
• Impact of frailty on outcomes in elderly patients with acute myocardial infarction who undergo percutaneous coronary intervention.1 passage
• Impact of limited English proficiency on presentation and clinical outcomes of patients undergoing primary percutaneous coronary intervention.1 passage
• Impact of operator volume for percutaneous coronary intervention on clinical outcomes: what do the numbers say?1 passage
• Impact of short-term complications of transcatheter aortic valve replacement on longer-term outcomes: results from the STS/ACC Transcatheter Valve Therapy Registry.1 passage
• Impact of socioeconomic status on incident heart failure and left ventricular dysfunction: systematic review and meta-analysis.1 passage
• Impact of the admitting ward on care quality and outcomes in non-ST-segment elevation myocardial infarction (NSTEMI): insights from a national registry.1 passage
• Implementation of appropriate use criteria for cardiology tests and procedures: a systematic review and meta-analysis.1 passage
• Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark 1997-2017.1 passage
• Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices).1 passage
• Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: Comparing common clinical risk scores and machine learning algorithms.1 passage
• Incidence and outcome of first myocardial infarction according to gender and age in Denmark over a 35-year period (1978-2012).1 passage
• Incidence of myocardial infarction in pregnancy: a systematic review and meta-analysis of population-based studies.1 passage
• Incident anaemia in older adults with heart failure: rate, aetiology, and association with outcomes.1 passage
• Incident atrial fibrillation and risk of psychoactive drug redemptions and psychiatric hospital contacts: a Danish Nationwide Register-based Follow-up Study.1 passage
• Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands.1 passage
• Increasing mortality from ischaemic heart disease in China from 2004 to 2010: disproportionate rise in rural areas and elderly subjects. 438 million person-years follow-up.1 passage
• Inequality in oral anticoagulation use and clinical outcomes in atrial fibrillation: a Danish nationwide perspective.1 passage
• Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an Observation from Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2).1 passage
• Is complete revascularization for multivessel disease during primary percutaneous coronary intervention associated with lower cardiovascular mortality? An updated meta-analysis and trial sequential of randomized trials.1 passage
• It's not ageing, stupid: why population ageing won't bankrupt health systems.1 passage
• Kidney function modifies the selection of treatment strategies and long-term survival in stable ischaemic heart disease: insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry.1 passage
• Left atrial appendage occlusion in the UK: prospective registry and data linkage to Hospital Episode Statistics.1 passage
• Linking hospital patient records for suspected or established acute coronary syndrome in a complex secondary care system: a proof-of-concept e-registry in National Health Service Scotland.1 passage
• Living alone is associated with all-cause and cardiovascular mortality: 32 years of follow-up in the Copenhagen Male Study.1 passage
• Long-term cardiovascular outcome, use of resources, and healthcare costs in patients with peripheral artery disease: results from a nationwide Swedish study.1 passage
• Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry.1 passage
• Long-term clinical outcomes, health-related quality of life, and costs in different treatment modalities of stable coronary artery disease.1 passage
• Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER).1 passage
• Long-term resource use patterns and healthcare costs after myocardial infarction in a clinical practice setting: results from a contemporary nationwide registry study.1 passage
• Long-term survival and fate of the leg in de novo intermittent claudication.1 passage
• Long-term trends of use of health service among heart failure patients.1 passage
• Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection.1 passage
• Longitudinal trajectories of hospital performance across targeted cardiovascular conditions in the USA.1 passage
• Low diagnostic yield of non-invasive testing in patients with suspected coronary artery disease: results from a large unselected hospital-based sample.1 passage
• Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013-17.1 passage
• Malignant disease as a comorbidity in patients with severe aortic stenosis: clinical presentation, outcomes, and management.1 passage
• Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry.1 passage
• Management of aortic stenosis: a systematic review of clinical practice guidelines and recommendations.1 passage
• Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations.1 passage
• Maternal cardiovascular complications at the time of delivery and subsequent re-hospitalization in the USA, 2010-16.1 passage
• Measuring the quality of perioperative care in cardiac surgery.1 passage
• Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).1 passage
• Mitral regurgitation management: a systematic review of clinical practice guidelines and recommendations.1 passage
• Modelling total coronary heart disease burden and long-term benefit of cholesterol lowering in middle aged men with and without a history of cardiovascular disease.1 passage
• Mortality burden in patients born with Ebstein's anomaly: a 40-year nationwide cohort study.1 passage
• Natural history of patients with insignificant coronary artery disease.1 passage
• Neurological effects of proprotein convertase subtilisin/kexin type 9 inhibitors: direct comparisons.1 passage
• New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome.1 passage
• Optimization of atrial fibrillation care: management strategies and quality measures.1 passage
• Organization of outcome-based quality improvement in Dutch heart centres.1 passage
• Out-of-hospital cardiac arrest attributable to sunshine: a nationwide, retrospective, observational study.1 passage
• Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study.1 passage
• Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study.1 passage
• Outcomes after coronary artery bypass grafting and percutaneous coronary intervention in diabetic and non-diabetic patients.1 passage
• Outcomes after surgery for functional tricuspid regurgitation: a systematic review and meta-analysis.1 passage
• Outcomes differ by first documented rhythm after witnessed out-of-hospital cardiac arrest in children: an observational study with prospective nationwide population-based cohort database in Japan.1 passage
• Patient Reported Outcomes Measures (PROMS) in Cardiovascular Disease.1 passage
• Patient profiles and health status outcomes for peripheral artery disease in high-income countries: a comparison between the USA and The Netherlands.1 passage
• Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic.1 passage
• Patient-Reported Versus Physician-Estimated Symptoms Before and After TAVR.1 passage
• Peak Oxygen Consumption Achieved at the End of Cardiac Rehabilitation Predicts Long-Term Survival in Patients with Coronary Heart Disease.1 passage
• Percutaneous coronary intervention vs. coronary artery bypass grafting for left main revascularization: an updated meta-analysis.1 passage
• Percutaneous vs. surgical revascularization for patients with unprotected left main stenosis: a meta-analysis of 5-year follow-up randomized controlled trials.1 passage
• Performance of acute coronary syndrome approaches in Brazil: a report from the BRACE (Brazilian Registry in Acute Coronary SyndromEs).1 passage
• Perioperative cardiovascular outcomes of non-cardiac solid organ transplant surgery.1 passage
• Permanent work disability in patients ≤50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study).1 passage
• Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis.1 passage
• Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation. A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.1 passage
• Poor quality of life in patients with and without frailty: co-prevalence and prognostic implications in patients undergoing percutaneous coronary interventions and cardiac catheterization.1 passage
• Potential for optimizing management of obesity in the secondary prevention of coronary heart disease.1 passage
• Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure.1 passage
• Prediction of cardiovascular risk in patients with familial hypercholesterolaemia.1 passage
• Prediction of residual angina after percutaneous coronary intervention.1 passage
• Predictors of cumulative cost for patients with severe aortic stenosis referred for surgical or transcatheter aortic valve replacement: a population-based study in Ontario, Canada.1 passage
• Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis.1 passage
• Predictors of quality of life in young adults with congenital heart disease.1 passage
• Preoperative heart failure worsens outcome after aortic valve replacement irrespective of left ventricular ejection fraction.1 passage
• Prevalence of venous thromboembolism in admissions and readmissions with and without syncope: a nationwide cohort study.1 passage
• Primary prevention of cardiovascular disease: global cardiovascular risk assessment and management in clinical practice.1 passage
• Privacy of patient data in quality-of-care registries in cardiology and cardiothoracic surgery: the impact of the new general data protection regulation EU-law.1 passage
• Prognostic impact of self-reported health on clinical outcomes in patients with heart failure.1 passage
• Prognostic value of high sensitivity troponin T after ST-segment elevation myocardial infarction in the era of cardiac magnetic resonance imaging.1 passage
• Prospective evaluation and long-term follow-up of patients referred to secondary care based upon natriuretic peptide levels in primary care.1 passage
• Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry.1 passage
• Protocols can lead to equitable emergency cardiac care for patients with language barriers, but quality communication remains important for access, outcomes, and prevention.1 passage
• Quality improvement initiative in pediatric echocardiography laboratory in a low to middle income country.1 passage
• Quality indicators in the management of elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.1 passage
• Quality of care and risk of incident atrial fibrillation in patients with newly-diagnosed heart failure: A nationwide cohort study.1 passage
• Quality of life following coronary artery bypass graft surgery vs. percutaneous coronary intervention in diabetics with multivessel disease: a five-year registry study.1 passage
• Randomized comparison of the clinical Outcome of single versus Multiple Arterial grafts: Quality of Life (ROMA:QOL) - Rationale and Study Protocol.1 passage
• Rapid rule out for suspected myocardial infarction: is the algorithm appropriate for all?1 passage
• Real world Data on the Concurrent Use of P-glycoprotein or Cytochrome 3A4 Drugs and Non-vitamin K Antagonist Oral Anticoagulants in Non-Valvular Atrial Fibrillation.1 passage
• Receiving care according to national heart failure guidelines is associated with lower total costs: an observational study in Region Halland, Sweden.1 passage
• Recurrent events analysis for examination of hospitalizations in heart failure: insights from the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) trial.1 passage
• Refined staging classification of cardiac damage associated with aortic stenosis and outcomes after transcatheter aortic valve implantation.1 passage
• Regional differences in coronary revascularization procedures and outcomes: a nationwide 11-year observational study.1 passage
• Relationship of depression screening in cardiometabolic disease with vascular events and mortality: findings from a large primary care cohort with 4 years follow-up.1 passage
• Remote monitoring and clinical outcomes: details on information flow and workflow in the IN-TIME study.1 passage
• Renal function is associated with long-term outcomes independent of degree of atherosclerosis: 6-year data from the Swedish Coronary Angiography and Angioplasty Registry.1 passage
• Reperfusion therapy for ST-elevation acute myocardial infarction in Eastern Europe: the ISACS-TC registry.1 passage
• Residual inflammatory risk after contemporary lipid lowering therapy.1 passage
• Rhythmic and haemodynamic determinants of long-term survival after radiofrequency ablation of atrial fibrillation in mitral valve surgery.1 passage
• Right ventricular pacing for hypertrophic obstructive cardiomyopathy: meta-analysis and meta-regression of clinical trials.1 passage
• Risk factors for 'microsize' vs. usual myocardial infarctions in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.1 passage
• Risk prediction models for out-of-hospital cardiac arrest outcomes in England.1 passage
• Risk scoring to guide antiplatelet therapy post-percutaneous coronary intervention for acute coronary syndrome results in improved clinical outcomes.1 passage
• Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes.1 passage
• Room for improvement: initiation of lipid-lowering treatment and achievement of lipid target levels-a Danish registry-based study.1 passage
• Serum Potassium As A Predictor Of Adverse Clinical Outcomes In Patients With Increasing Comorbidity Burden.1 passage
• Sex Differences in Mortality and 90-day Readmission Rates after Transcatheter aortic valve replacement (TAVR): A Nationwide Analysis from the United States.1 passage
• Sex differences in post-traumatic stress disorder in cardiovascular patients after the Great East Japan Earthquake: a report from the CHART-2 Study.1 passage
• Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions.1 passage
• Short- vs. long-term dual antiplatelet therapy in secondary prevention for ischaemic stroke: a network metanalysis.1 passage
• Should fractional flow reserve follow angiographic visual inspection to guide preventive percutaneous coronary intervention in ST-elevation myocardial infarction?1 passage
• Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? a nationwide cohort study.1 passage
• Significant regional variation in use of implantable cardioverter-defibrillators in Denmark.1 passage
• Simple risk models to predict cardiovascular death in patients with stable coronary artery disease.1 passage
• Sixty-day readmission rate after percutaneous coronary intervention: predictors and impact on long-term outcomes.1 passage
• Skeletal and soft tissue injuries after manual and mechanical chest compressions.1 passage
• Societal costs of venous thromboembolism and subsequent major bleeding events: a national register-based study.1 passage
• Socioeconomic differences in outcomes after hospital admission for atrial fibrillation or flutter.1 passage
• Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials.1 passage
• Statin dose titration patterns and subsequent major cardiovascular events in very high-risk patients: estimates from Swedish population-based registry data.1 passage
• Stroke prevention with direct oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk.1 passage
• Study design, result posting and publication of late-stage cardiovascular trials.1 passage
• Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic.1 passage
• Survival and incidence of cardiovascular diseases in participants in a long-distance ski race (Vasaloppet, Sweden) compared with the background population.1 passage
• Systematic review and meta-analysis to compare outcomes between intermediate- and high-risk patients undergoing transcatheter aortic valve implantation.1 passage
• Systematic review of the cost-effectiveness of transcatheter interventions for valvular heart disease.1 passage
• Temporal trends and socioeconomic differences in the incidence of left-sided valvular heart disease in Denmark.1 passage
• Temporal trends in adoption and outcomes of transcatheter aortic valve implantation: a SwissTAVI Registry analysis.1 passage
• Temporal trends of cardiovascular health factors among 366 270 French adults.1 passage
• The Association between Cardiovascular Disease Admission Rates and The Coronavirus Disease 2019 Lockdown and Reopening of a Nation: a Danish Nationwide Cohort Study.1 passage
• The Cost-Effectiveness of One-Time Opportunistic Screening for Atrial Fibrillation in Different Age Cohorts of Inhabitants in Denmark Aged 65 Years and Above. A Markov Modelled Analysis.1 passage
• The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry.1 passage
• The ESC-EORP Chronic Ischaemic Cardiovascular Disease Long Term (CICD LT) registry.1 passage
• The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry.1 passage
• The Influence of the 2020 COVID-19 Pandemic on the Implantation Rates of Cardiac Implantable Electronic Devices (CIEDs) in Germany.1 passage
• The Myocardial Ischaemia National Audit Project (MINAP).1 passage
• The PRECISE-DAPT score and five-year outcomes after percutaneous coronary intervention: a large-scale, real-world study from China.1 passage
• The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry).1 passage
• The association of depression at any time to the risk of death following coronary artery disease diagnosis.1 passage
• The association of invasive treatment with health status outcomes in patients with non-ST-elevation myocardial infarction and pre-infarct angina.1 passage
• The burden of atherosclerosis in Portugal.1 passage
• The contribution of the composite of clinical process indicators as a measure of hospital performance in the management of acute coronary syndromes-insights from the CONCORDANCE registry.1 passage
• The cost implication of primary prevention in the HOPE 3 trial.1 passage
• The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis.1 passage
• The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: The FinACAF Study.1 passage
• The effect of schizophrenia on major adverse cardiac events, length of hospital stay, and prevalence of somatic comorbidities following acute coronary syndrome.1 passage
• The impact of cultural and linguistic diversity on hospital readmission in patients hospitalized with acute heart failure.1 passage
• The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review.1 passage
• The importance of considering both primary and secondary diagnostic codes when using administrative health data to study acute coronary syndrome epidemiology (ANZACS-QI 47).1 passage
• The importance of structures and processes in determining outcomes for abdominal aortic aneurysm repair: an international perspective.1 passage
• The incidence and relevance of site-reported vs. patient-reported angina: insights from the ABSORB II randomized trial comparing Absorb everolimus-eluting bioresorbable scaffold with XIENCE everolimus-eluting metallic stent.1 passage
• The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction.1 passage
• The influence of the baseline 10-year atherosclerotic cardiovascular disease risk on cardiovascular outcomes with aspirin for primary prevention: a meta-regression analysis.1 passage
• The obesity paradox, extreme obesity, and long-term outcomes in older adults with ST-segment elevation myocardial infarction: results from the NCDR.1 passage
• The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis.1 passage
• The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review.1 passage
• The utility of implantable loop recorders (ILR) in patient management: an age and indication stratified study in the outpatient-implant era.1 passage
• Thirteen-Year Trends in Cardiovascular Risk in Men and Women with Chronic Coronary Syndrome.1 passage
• Thromboembolisms related to post-operative electrical cardioversions for atrial fibrillation in patients with surgical aortic valve replacement.1 passage
• Time to hospital arrival among patients with acute myocardial infarction in China: a report from China PEACE prospective study.1 passage
• Timely publication and sharing of trial data: opportunities and challenges for comparative effectiveness research in cardiovascular disease.1 passage
• Timing of percutaneous coronary intervention in patients with non-ST-elevation myocardial infarction: a SWEDEHEART study.1 passage
• Transcatheter Aortic Valve Replacement in Mixed Aortic Valve Disease: A Systematic Review and Meta-analysis.1 passage
• Treatment of Older Patients with Atrial Fibrillation by Morbidity Burden.1 passage
• Trends in acute pericarditis hospitalizations and outcomes among the elderly in the USA, 1999-2012.1 passage
• Trends in mortality and major complications for patients undergoing coronary artery bypass grafting among Urban Teaching Hospitals in China: 2004 to 2013.1 passage
• Trends in preadmission oral anticoagulant use and clinical outcome in atrial fibrillation patients admitted with acute stroke in Denmark.1 passage
• Tricuspid regurgitation management: a systematic review of clinical practice guidelines and recommendations.1 passage
• True-severe stenosis in paradoxical low-flow low-gradient aortic stenosis: outcomes after transcatheter aortic valve replacement.1 passage
• Tuning and External Validation of an Adult Congenital Heart Disease Risk Prediction Model.1 passage
• Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry.1 passage
• Type-II myocardial infarction and chronic myocardial injury rates, invasive management, and 4-year mortality among consecutive patients undergoing high-sensitivity troponin T testing in the emergency department.1 passage
• Types of myocardial injury and mid-term outcomes in patients with COVID-19.1 passage
• Underrepresentation of sex in reporting traditional and emerging biomarkers for primary prevention of cardiovascular disease: a systematic review.1 passage
• Unlocking the potential of value-based health care by defining global standard sets of outcome measures that matter to patients with cardiovascular diseases.1 passage
• Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registry.1 passage
• Use of relative survival to evaluate non-ST-elevation myocardial infarction quality of care and clinical outcomes.1 passage
• Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction.1 passage
• Utilization and outcomes of early respiratory support in 6.5 million acute heart failure hospitalizations.1 passage
• Utilization of diagnostic resources and costs in patients with suspected cardiac chest pain.1 passage
• Validation of European Society of Cardiology pre-test probabilities for obstructive coronary artery disease in suspected stable angina.1 passage
• Validation of the European Society of Cardiology and European Society of Anaesthesiology non-cardiac surgery risk score in patients treated with coronary drug-eluting stent implantation.1 passage
• Variation in preoperative antithrombotic strategy, severe bleeding, and use of blood products in coronary artery bypass grafting: results from the multicentre E-CABG registry.1 passage
• What really matters: a patient-centered instrument to evaluate health-related quality of life in cardiovascular disease.1 passage
• Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).1 passage
• Will the COVID-19 Epidemic Reshape Cardiology?1 passage